My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Bio-Rad Laboratories (BIO)
BIO nyse
United States
Bio-Rad Laboratories

Bio-Rad Laboratories Stock Analysis & Ratings

Bio-Rad Laboratories Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Bio-Rad Laboratories stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


BIO Stock Stats

Previous Close$736.8
Bid0 x 0
Ask0 x 0
Today’s Range$741.36 - $768.98
52-Week Range$507.22 - $832.70
Average Volume116.24K
Market Cap$21.84B
P/E Ratio3.3
Earnings DateFeb 24, 2022

Company Description

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Medical Devices & Instruments
Norman Schwartz
1000 Alfred Nobel Drive, Hercules, CA, 94547, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Bio-Rad Laboratories’s price range in the past 12 months?
Bio-Rad Laboratories lowest stock price was $507.22 and its highest was $832.70 in the past 12 months.
    What is Bio-Rad Laboratories’s market cap?
    Bio-Rad Laboratories’s market cap is $21.84B.
      What is Bio-Rad Laboratories’s price target?
      Currently, no data Available
      What do analysts say about Bio-Rad Laboratories?
      Not enough analysts have published a price target to provide an average price target.
      When is Bio-Rad Laboratories’s upcoming earnings report date?
      Bio-Rad Laboratories’s upcoming earnings report date is Feb 24, 2022 which is in 89 days.
        How were Bio-Rad Laboratories’s earnings last quarter?
        Bio-Rad Laboratories released its earnings results on Oct 28, 2021. The company reported $3.71 earnings per share for the quarter, beating the consensus estimate of $2.437 by $1.273.
          Is Bio-Rad Laboratories overvalued?
          According to Wall Street analysts Bio-Rad Laboratories’s price is currently Overvalued.
            Does Bio-Rad Laboratories pay dividends?
            Bio-Rad Laboratories does not currently pay dividends.
            What is Bio-Rad Laboratories’s EPS estimate?
            Bio-Rad Laboratories’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bio-Rad Laboratories have?
            Bio-Rad Laboratories has 29,920,000 shares outstanding.
              What happened to Bio-Rad Laboratories’s price movement after its last earnings report?
              Bio-Rad Laboratories reported an EPS of $3.71 in its last earnings report, beating expectations of $2.437. Following the earnings report the stock price went up 3.931%.
                Which hedge fund is a major shareholder of Bio-Rad Laboratories?
                Among the largest hedge funds holding Bio-Rad Laboratories’s share is Fisher Asset Management LLC. It holds Bio-Rad Laboratories’s shares valued at 109M.

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis